HF
BIAF icon

HRT Financial’s bioAffinity Technologies BIAF Stock Holding History

HRT Financial’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+1,389
New +$42.6K ﹤0.01% 3949
2025
Q2 		– Sell
-42
Closed -$4K – 2623
2025
Q1 		$4K Buy
+42
New +$11.5K ﹤0.01% 2410

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial's BIAF Position: Q2 2026 in Review

HRT Financial opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 1,389 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #3949 among its holdings. This is a return to the name: HRT Financial previously reported a position in BIAF as recently as Q1 2025.

HRT Financial first reported a position in BIAF in Q1 2025 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • HRT Financial held 1,389 shares of bioAffinity Technologies worth $16K as of Q2 2026.
  • bioAffinity Technologies was a new HRT Financial position in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3949 holding.
  • HRT Financial first reported a position in bioAffinity Technologies in Q1 2025 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.